Rossi EA - Search Results

1

Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers.

Cardillo TM, Govindan SV, Sharkey RM, Trisal P, Arrojo R, Liu D, Rossi EA, Chang CH, Goldenberg DM. Cardillo TM, et al. Among authors: rossi ea. Bioconjug Chem. 2015 May 20;26(5):919-31. doi: 10.1021/acs.bioconjchem.5b00223. Epub 2015 May 8. Bioconjug Chem. 2015. PMID: 25915780

2

A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.

Gold DV, Goldenberg DM, Karacay H, Rossi EA, Chang CH, Cardillo TM, McBride WJ, Sharkey RM. Gold DV, et al. Among authors: rossi ea. Cancer Res. 2008 Jun 15;68(12):4819-26. doi: 10.1158/0008-5472.CAN-08-0232. Cancer Res. 2008. PMID: 18559529

3

Novel designs of multivalent anti-CD20 humanized antibodies as improved lymphoma therapeutics.

Rossi EA, Goldenberg DM, Cardillo TM, Stein R, Wang Y, Chang CH. Rossi EA, et al. Cancer Res. 2008 Oct 15;68(20):8384-92. doi: 10.1158/0008-5472.CAN-08-2033. Cancer Res. 2008. PMID: 18922911

4

A new method to produce monoPEGylated dimeric cytokines shown with human interferon-α2b.

Chang CH, Rossi EA, Cardillo TM, Nordstrom DL, McBride WJ, Goldenberg DM. Chang CH, et al. Among authors: rossi ea. Bioconjug Chem. 2009 Oct 21;20(10):1899-907. doi: 10.1021/bc9001773. Epub 2009 Sep 8. Bioconjug Chem. 2009. PMID: 19736932

5

Improved 18F labeling of peptides with a fluoride-aluminum-chelate complex.

McBride WJ, D'Souza CA, Sharkey RM, Karacay H, Rossi EA, Chang CH, Goldenberg DM. McBride WJ, et al. Among authors: rossi ea. Bioconjug Chem. 2010 Jul 21;21(7):1331-40. doi: 10.1021/bc100137x. Bioconjug Chem. 2010. PMID: 20540570 Free PMC article.

6

The dock-and-lock method combines recombinant engineering with site-specific covalent conjugation to generate multifunctional structures.

Rossi EA, Goldenberg DM, Chang CH. Rossi EA, et al. Bioconjug Chem. 2012 Mar 21;23(3):309-23. doi: 10.1021/bc2004999. Epub 2012 Jan 10. Bioconjug Chem. 2012. PMID: 22168393 Review.

7

A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancers.

Sharkey RM, van Rij CM, Karacay H, Rossi EA, Frielink C, Regino C, Cardillo TM, McBride WJ, Chang CH, Boerman OC, Goldenberg DM. Sharkey RM, et al. Among authors: rossi ea. J Nucl Med. 2012 Oct;53(10):1625-32. doi: 10.2967/jnumed.112.104364. Epub 2012 Sep 5. J Nucl Med. 2012. PMID: 22952342 Free article.

8

Optimization of multivalent bispecific antibodies and immunocytokines with improved in vivo properties.

Rossi EA, Chang CH, Cardillo TM, Goldenberg DM. Rossi EA, et al. Bioconjug Chem. 2013 Jan 16;24(1):63-71. doi: 10.1021/bc300488f. Epub 2012 Dec 21. Bioconjug Chem. 2013. PMID: 23116517

9

Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer.

Liu D, Cardillo TM, Wang Y, Rossi EA, Goldenberg DM, Chang CH. Liu D, et al. Among authors: rossi ea. Mol Cancer. 2014 Mar 10;13:53. doi: 10.1186/1476-4598-13-53. Mol Cancer. 2014. PMID: 24606732 Free PMC article.

10

Redirected T-cell killing of solid cancers targeted with an anti-CD3/Trop-2-bispecific antibody is enhanced in combination with interferon-α.

Rossi EA, Rossi DL, Cardillo TM, Chang CH, Goldenberg DM. Rossi EA, et al. Among authors: rossi dl. Mol Cancer Ther. 2014 Oct;13(10):2341-51. doi: 10.1158/1535-7163.MCT-14-0345. Epub 2014 Jul 22. Mol Cancer Ther. 2014. PMID: 25053819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters